These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1479229)

  • 1. [Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Akai M; Ishizaki T; Idemura Y; Sasaki F; Nakai T; Miyaho S; Matsubara R; Uchiki H; Nakaguki K
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1863-4. PubMed ID: 1479229
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.
    Rajapakse S; Abeynaike L; Wickramarathne T
    J Clin Psychopharmacol; 2010 Oct; 30(5):620-2. PubMed ID: 20814334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome without withdrawal of levodopa.
    Singla R; Singla A; Kumar S; Kar P
    Natl Med J India; 2009; 22(3):162. PubMed ID: 19764697
    [No Abstract]   [Full Text] [Related]  

  • 4. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O; Salachas F; Montastruc JL
    Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute myopathy caused by psychotropic agents. Report of 2 cases].
    Romanelli R; Borghesi MR; Novaro G
    Pathologica; 1988; 80(1070):711-6. PubMed ID: 2907931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant-like neuroleptic syndrome: a sign to call attention to].
    Segado Soriano A; García Castaño J; del Toro Cervera J; Muiño Miguez A
    An Med Interna; 1995 Sep; 12(9):466-7. PubMed ID: 8924562
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 11. An unrecognised case of withdrawal neuroleptic malignant syndrome: a case report.
    Ball H; de Waal H; Craig K
    Med Sci Law; 2009 Oct; 49(4):298-300. PubMed ID: 20025106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
    Hirschorn KA; Greenberg HS
    Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
    [No Abstract]   [Full Text] [Related]  

  • 13. The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
    Li W; Saweris M; Madhira B
    Am J Ther; 2018; 25(5):e606-e607. PubMed ID: 28731860
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis, acute renal failure, and compartment syndrome in a child with parainfluenza type 1 infection.
    Ebbeson RL; De Kock MJ; Penny N; Kollman TR
    Pediatr Infect Dis J; 2009 Sep; 28(9):850-2. PubMed ID: 19684526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal pseudo-obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient.
    Shimada J; Sakakibara R; Uchiyama T; Liu Z; Yamamoto T; Ito T; Mori M; Asahina M; Hattori T
    Eur J Neurol; 2006 Mar; 13(3):306-7. PubMed ID: 16618352
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS; Walker R; Shill HA
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH; Feinberg SS; Feldman RG
    JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant neuroleptic syndrome associated with myocardial infarction, acute renal insufficiency and rhabdomyolysis].
    Benatar Haserfaty J; García Pérez del Río J; Román Tabernero M; Durán Insúa F; Ascorve Domínguez A
    Rev Esp Anestesiol Reanim; 1991; 38(4):261-4. PubMed ID: 1685257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.